Records 1 - 30 (of 43 Records) |
Query Trace: Other[original query] |
---|
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) China, 2020
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team et al. China CDC Weekly 2020 10.46234/ccdcw2020.032
Summary:
Not in Science Update
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Mental Health Needs of Health Care Workers Providing Frontline COVID-19 Care
Ayanian, John Z. et al.JAMA Health Forum 10.1001/jamahealthforum.2020.0397
Summary:
Factors including emotional strain, physical exhaustion, caring for coworkers, shortages of PPE and medical equipment, and concerns about infecting family contribute to the psychological distress of health care workers providing direct frontline care to patients with COVID-19.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic
Mehta, Bella et al.JAMA Health Forum 10.1001/jamahealthforum.2020.0438
Summary:
Brings attention to how shortages of hydroxychloroquine (HCQ) might affect socioeconomically vulnerable patients with lupus treated with HCQ and in remission.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
NIH begins study to quantify undetected cases of coronavirus infection
National Institutes of Health et al. National Institutes of Health Press Release 2020
Summary:
Anyone can volunteer to be screened for participation and collect their own microsample of blood at home to send in.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
To streamline coronavirus vaccine and drug efforts, NIH and firms join forces
Kaiser, Jocelyn et al. Science Magazine 2020
Summary:
Describes the ACTIV initiative, a public-private partnership between NIH, pharma, and biotech companies to coordinate efforts to conduct clinical trials of drugs and vaccines.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Crushing coronavirus means breaking the habits of a lifetime. Behavior scientists have some tips
Cornwall, Warren et al. Science Magazine 2020
Summary:
Notes how government and industry leaders are turning to behavioral scientists for advice on how to persuade people to abide by public health interventions.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Antibiotic treatment for COVID-19 complications could fuel resistant bacteria
Reardon, Sara et al. Science Magazine 2020
Summary:
Discusses the possible impact on development of antibiotic resistance.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
Food and Drug Administration et al. Food and Drug Administration Press Release 2020
Summary:
On May 1, 2020 the FDA issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease, two days after the National Institutes of Healths clinical trial showed promising results.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19
National Institutes of Allergy and Infectious Diseases et al. News Release 2020
Summary:
According to a recent news release, preliminary data from a larger clinical trial, the Adaptive COVID-19 Treatment Trialexternal icon, demonstrated that recovery times among 1,063 hospitalized COVID-19 patients with mostly severe disease were 31% shorter (11 days vs 15 days; p <0.001). Mortality was lower among those who received remdesivir than those who did not (8.0% vs 11.6%), but the difference was not statistically significant (p = 0.059).
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Watch the coronavirus rampage through the body
Cantwell, Meagan et al. Science Magazine 2020 10.1126/science.abc8046
Summary:
4-minute video that demonstrates the pathogenesis of SARS CoV-2 infection throughout the entire body.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease 2019 (COVID-19)
Zhang, Yong et al. China CDC Weekly 2020 10.46234/ccdcw2020.033
Summary:
Live SARS-CoV-2 virus was visualized by electron microscopy from a culture inoculated with stool of a person with severe COVID-19 disease 15 days after symptoms onset.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Why do some COVID-19 patients infect many others, whereas most dont spread the virus at all
Kupferschmidt, Kai et al. Science Magazine 2020 10.1126/science.abc8931
Summary:
Provides possible reasons some people may transmit COVID-19 while others do not, including variability in viral shedding and social distancing.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Shoring Up the US Safety Net in the Era of Coronavirus Disease 2019
Mullangi, Samyukta et al. JAMA Health Forum 2020 10.1001/jamahealthforum.2020.0730
Summary:
Discusses how the structure of safety-net hospitals puts them in a unique position to endure the COVID-19 pandemic and that with enough resources they can adequately serve underinsured and uninsured persons while also providing financial protection to neighboring hospitals.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Safely Reopening SchoolsLearning Amid a Pandemic
Buntin, Melinda B. et al. JAMA Health Forum 2020 10.1001/jamahealthforum.2020.1054
Summary:
Outline of several interventions to facilitate safe school reopening, including mask wearing, grouping small numbers of students together, and changing absence policies.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Why COVID-19 is more deadly in people with obesityeven if theyre young
Wadman, Meredith et al. Science Magazine 2020 10.1126/science.abe7010
Summary:
Reviews the increased risks of COVID-19 to individuals with obesity. The review describes potential causes for the increased risk of hospitalization.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Ethical or exploitativeshould prisoners participate in COVID-19 vaccine trials
Cahan, Eli et al. Science Magazine 2020 10.1126/science.abe7861
Summary:
Incarcerated populations are typically excluded from clinical trials over ethical concerns. A bioethicist and sociologist/epidemiologist discuss the benefits and risks of enrolling incarcerated persons in COVID-19 vaccine trials.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
WHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await
Kupferschmidt, Kai et al. Science Magazine 2020 10.1126/science.abe8953
Summary:
Challenges the WHO faces in distributing future COVID-19 vaccines outside of high-income countries.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
One number could help reveal how infectious a COVID-19 patient is. Should test results include it
Service, Robert F. et al. Science Magazine 2020 10.1126/science.abf0366
Summary:
Ct values, which are proportional to viral loads, theoretically could be useful to guide patient care, but variations in Ct values due to assay design or instrument performance make standardization challenging.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Retinal Vein Occlusion Associated With COVID-19
Kapatayes, Nuha et al.Retina Today
Summary:
Case report of central retinal vein occlusion in a patient with COVID-19.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Does Remdesivir Actually Work
Sax, Paul E et al.HIV and ID Observations
Summary:
Implications: Although the Adaptive COVID-19 Treatment Trial external icon indicates that remdesivir reduces time to recovery, in this larger trial there were no differences in time to hospital discharge or in mortality. An editorialexternal icon discusses these disparate results. Findings from this trial are consistent with results from the larger RECOVERY trial for hydoxycholoroquineexternal icon, and lopinavir plus ritonavirexternal icon. Taken together, the benefit of remdesivir is unclear. However, it appears none of the other potential drugs studied here for COVID-19 treatment have significant effect on mortality.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
StatementNIH-Sponsored ACTIV-3 Trial Closes LY-CoV555 Sub-Study
National Institutes of Allergy and Infectious Diseases et al. National Institutes of Allergy and Infectious Diseases Statement 2020
Summary:
Implications: While another trial of LY-CoV555 was recently stopped given apparent lack of clinical benefit in hospitalized COVID-19 patientsexternal icon, LY-CoV555, known as banlanivimab, effects on early mild or moderate COVID-19 were effective enough for an FDA emergency use authorizationexternal icon issued November 9, 2020.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
Food and Drug Administration et al. Food and Drug Administration Press Release 2020
Summary:
Implications: While another trial of LY-CoV555 was recently stopped given apparent lack of clinical benefit in hospitalized COVID-19 patientsexternal icon, LY-CoV555, known as banlanivimab, effects on early mild or moderate COVID-19 were effective enough for an FDA emergency use authorizationexternal icon issued November 9, 2020.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Mutant coronaviruses found in mink spark massive culls and doom a Danish groups research
Lest-Lasserre, Christa et al. Science Magazine 2020 10.1126/science.abf6565
Summary:
Implications: SARS-CoV-2 outbreaks in mink farms are well-documented and resulted in recently-abandoned plans to cull Denmarks 17 million minksexternal icon. This paper provides phylogenetic data suggestive of mink-to-human SARS-CoV-2 transmission; however, directionality of transmission is challenging to definitively demonstrate using phylogenetics. Concerns about potential mutations in SARS-CoV-2 from animal-to-human transmission that may lead to more rapid spread or jeopardize vaccine efficacyexternal icon may be premature.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Declining COVID-19 Case Fatality Rates across all ages: analysis of German data
Oke, Jason et al. Evidence Service to support the COVID-19 response 2020
Summary:
Improved survival of patients with COVID-19 over time in Germany
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Industry Sectors Highly Affected by Worksite Outbreaks of Coronavirus Disease, Los Angeles County, California, USA, March 19-September 30, 2020.
Contreras Zuelma et al. Emerging infectious diseases 2021 5 (7) 1769-1775
Summary:
Nearly 60% of 698 nonhealthcare worksite COVID-19 outbreaks occurred in 3 sectors: manufacturing (26.4%), retail trade (19.6%), and transportation and warehousing (10.5%). Outbreaks were larger and longer in facilities with more on-site staff.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
In Coronavirus Fight, Robots Report For Disinfection Duty
Blake, Rich et al. Forbes 2020
Summary:
Robots are fighting the spread of COVID-19, too: A healthcare-sector supplier in Texas has sent UV-light-zapping germicidal robots around the world, including to U.S. hospitals.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Singapore deploys robot 'dog' to encourage social distancing
Toh, Michelle et al. CNN Business 2020
Summary:
Robots are fighting the spread of COVID-19, too: To encourage social distancing, Singapore deployed Spot, the robot dog.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
COVID-19: SKorean cafe hires robots to serve coffee amid social distancing
Kenechukwu, Stephen et al. The Cable Lifestyle 2020
Summary:
Robots are fighting the spread of COVID-19, too: A cafe in South Korea has hired robot baristas.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Revealing the Toll of COVID-19: A Technical Package for Rapid Mortality Surveillance and Epidemic Response
Vital Strategies, et al. World Health Organizaiton Report 2020
Summary:
WHO guidance on implementing rapid mortality surveillance in the context of the COVID-19 pandemic, with a focus on low resource settings.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
COVID-19 and the drug supply chain: from production and trafficking to use
United Nations Office on Drugs and Crime et al. Research Brief 2020
Summary:
The association between timing of the COVID-19 pandemic and increases in fatal overdoses is not yet understood. Possible contributing factors include... interruptions to/changes in the illicit drug supply.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure